London Daily

Focus on the big picture.
Thursday, Jul 10, 2025

Oxford, WHO scientists say more data needed on AstraZeneca's Covid vaccine trials

Oxford, WHO scientists say more data needed on AstraZeneca's Covid vaccine trials

More data is needed from AstraZeneca's Covid vaccine trials beyond what was presented in a press release, experts from the WHO and Oxford University said.

More data will be needed from AstraZeneca’s coronavirus vaccine trials to determine the drug’s safety and efficacy following concerns from experts in the U.S., scientists from the University of Oxford and the World Health Organizations said on Friday.

“There’s always a problem in announcing scientific results by press release, and that is that you don’t have all the data out there and people aren’t able to really look and think about the data properly,” Sir John Bell, the Regius professor of medicine at Oxford University, told CNBC’s “Closing Bell” on Friday.

Shares of AstraZeneca dipped this week after the company announced interim results from its coronavirus vaccine trials on Monday. The British pharmaceutical giant said its vaccine, which it’s developing alongside Oxford, was 70% effective after it combined results from two different dosing regimes.

One smaller group of people, all under the age of 55, received an unintentionally lower dose of the vaccine followed by a full dose, and a larger group of people received two full doses of the vaccine. The vaccine was found to be 90% effective in the group that received the smaller dose while the larger group showed only 62% effectiveness.

Some U.S. experts, including Moncef Slaoui, chief of the White House’s Operation Warp Speed, said they were concerned about the differing ages between the two groups. Amid those concerns, Pascal Soriot, CEO of AstraZeneca, told Bloomberg on Thursday that the company will likely begin a new study to examine the lower dosage regime.

“The full data will be published in the medical journal so people can examine it. Taking snippets of data is not a helpful way to make an analysis of what’s actually going on,” Bell told CNBC on Friday.

Other British government ministers and experts have also backed AstraZeneca’s vaccine, noting that drug regulators who have more information on the vaccine’s late-stage clinical trials will ultimately have the final say. Britain asked its medicine regulator on Friday to assess the vaccine for a temporary supply, which means the vaccine could be distributed in the country before the end of the year.


That process could take longer in the U.S., however, amid recent concerns. Bell told CNBC that he predicts the UK could be “substantially vaccinated” by spring of next year.

Kate O’Brien, director of immunization, vaccines and biologicals at WHO, agreed with Bell during the organization’s press briefing earlier on Friday, saying that there’s only a “limited amount that can be said in a press release” and that more information, including how well the vaccine builds an immune response, is needed.

“It’s difficult to weigh in on this,” O’Brien said from the WHO’s Geneva headquarters. “From what we understand about the press release, there is certainly something interesting that has been observed, but there are many reasons that could underlie the differences that were observed.”

Dr. Soumya Swaminathan, WHO’s chief scientist, concurred and said AstraZeneca’s trial figures “are still too small to really come to any definitive conclusions.” Less than 3,000 trial participants were in the group that was given the smaller dose of the company’s vaccine compared with more than 8,000 in the larger group.

“If we are to explore this hypothesis of having perhaps a better efficacy with the lower dose, then it would need a trial,” Swaminathan said.

Newsletter

Related Articles

0:00
0:00
Close
Severe Heatwave Claims 2,300 Lives Across Europe
NVIDIA Achieves Historic Milestone as First Company Valued at $4 Trillion
Declining Beer Consumption Signals Cultural Shift in Germany
Linda Yaccarino Steps Down as CEO of X After Two Years
US Imposes New Tariffs on Brazilian Exports Amid Political Tensions
Azerbaijan and Armenia are on the brink of a historic peace deal.
Emails Leaked: How Passenger Luggage Became a Side Income for Airport Workers
Polish MEP: “Dear Leftists - China is laughing at you, Russia is laughing, India is laughing”
BRICS Expands Membership with Indonesia and Ten New Partner Countries
Weinstein Victim’s Lawyer Says MeToo Movement Still Strong
U.S. Enacts Sweeping Tax and Spending Legislation Amid Trade Policy Shifts
Football Mourns as Diogo Jota and Brother André Silva Laid to Rest in Portugal
Labour Expected to Withdraw Support for Special Needs Funding Model
Leaked Audio Reveals Tory Aide Defending DEI Record
Elon Musk Founds a Party Following a Poll on X: "You Wanted It – You Got It!"
London Stock Exchange Faces Historic Low in Initial Public Offerings
A new online platform has emerged in the United Kingdom, specifically targeting Muslim men seeking virgin brides
Trump Celebrates Independence Day with B-2 Flyover and Signs Controversial Legislation
Boris Johnson Urges Conservatives to Ignore Farage
SNP Ordered to Update Single-Sex Space Guidance Within Days
Starmer Set to Reject Calls for Wealth Taxes
Stolen Century-Old Rolls-Royce Recovered After Hotel Theft
Macron Presses Starmer to Recognise Palestinian State
Labour Delayed Palestine Action Ban Over Riot Concerns
Swinney’s Tax Comments ‘Offensive to Scots’, Say Tories
High Street Retailers to Enforce Bans on Serial Shoplifters
Music Banned by Henry VIII to Be Performed After 500 Years
Steve Coogan Says Working Class Is Being ‘Ethnically Cleansed’
Home Office Admits Uncertainty Over Visa Overstayer Numbers
JD Vance Questions Mandelson Over Reform Party’s Rising Popularity
Macron to Receive Windsor Carriage Ride in Royal Gesture
Labour Accused of ‘Hammering’ Scots During First Year in Power
BBC Head of Music Stood Down Amid Bob Vylan Controversy
Corbyn Eyes Hard-Left Challenge to Starmer’s Leadership
London Tube Trains Suspended After Major Fire Erupts Nearby
Richard Kemp: I Felt Safer in Israel Under Attack Than in the UK
Cyclist Says Police Cited Human Rights Act for Riding No-Handed
China’s Central Bank Consults European Peers on Low-Rate Strategies
AI Raises Alarms Over Long-Term Job Security
Saudi Arabia Maintains Ties with Iran Despite Israel Conflict
Musk Battles to Protect Tesla Amid Trump Policy Threats
Air France-KLM Acquires Majority Stake in Scandinavian Airlines
UK Educators Sound Alarm on Declining Child Literacy
Shein Fined €40 Million in France Over Misleading Discounts
Brazil’s Lula Visits Kirchner During Argentina House Arrest
Trump Scores Legislative Win as House Passes Tax Reform Bill
Keir Starmer Faces Criticism After Rocky First Year in Power
DJI Launches Heavy-Duty Coaxial Quadcopter with 80 kg Lift Capacity
U.S. Senate Approves Major Legislation Dubbed the 'Big Beautiful Bill'
Largest Healthcare Fraud Takedown in U.S. History Announced by DOJ
×